Valentino K

Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada.

4 papers · ORCID

ArticleKetamine

Are the current safety measures for the treatment of depression with esketamine sufficient?

Valentino K, Teopiz KM, Dri CE +3

Europe PMC2026
ArticleKetamine

The effect of glutamatergic modulators on sleep behavior and architecture in depressive disorders: A systematic review.

Valentino K, Ballum H, Cheung W +11

Europe PMC2026
ArticleKetamine

Should glutamatergic modulators be considered preferential treatments for adults with major depressive disorder and a reported history of trauma? Conceptual and clinical implications.

Teopiz KM, Lo HKY, Lakhani M +11

Europe PMC2025
ArticleKetamine

The Effects of Ketamine and Esketamine on Measures of Quality of Life in Major Depressive Disorder and Treatment-Resistant Depression: A Systematic Review.

Cheng MCH, Dri CE, Ballum H +5

Europe PMC2025